ENDPOINTS

Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy

Plus, news about Applied Therapeutics and Acadia: ❤️ Ionis’ Phase 3 data for cardio drug: It said that two different doses of olezarsen reduced triglycerides by a placebo-adjusted 61% and 58 ...

May 19, 2025 - 15:24
 0
Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy
Plus, news about Applied Therapeutics and Acadia: ❤️ Ionis’ Phase 3 data for cardio drug: It said that two different doses of olezarsen reduced triglycerides by a placebo-adjusted 61% and 58 ...
Read More

Tags:

Previous Article

Facing the storm: Researchers model a new line of coastal defense with horizonta...

Next Article

Seaweed surges may alter Arctic fjord carbon dynamics

Related Posts

Top RFK Jr. advisor dares drugmakers over threats to drop manufacturing promises

Top RFK Jr. advisor dares drugmakers over threats to dr...

May 15, 2025  0

Pathos AI collects $365M to fuel data-driven oncology studies

Pathos AI collects $365M to fuel data-driven oncology s...

May 15, 2025  0

Pharma investors brush off Trump’s ‘most favored nation’ plan as stocks rise

Pharma investors brush off Trump’s ‘most favored nation...

May 12, 2025  0